From: Chaperone use during intimate examinations in primary care: postal survey of family physicians
Examination
Percent Reporting Use of Chaperone (n = 257)*
Female Pelvic
53%
Female Rectal
43%
Female Breast
41%
Male Genital
23%
Male Rectal
18%